[Income Statement for JW Daihan Pharmaceutical co. (Korean Won 00'000'000] | ||||||
2009Y | 2010Y | 2011Y | 2012Y | 2013Y | 1Q/2014 | |
Revenue | 4,551 | 4,433 | 4,310 | 3,971 | 3,942 | 930 |
Revenue Growth | -2.59% | -2.77% | -7.87% | -0.73% | ||
COGS | 2,691 | 2,818 | 2,830 | 2,681 | 2,497 | 570 |
% of Revenue | 59.13% | 63.57% | 65.66% | 67.51% | 63.34% | 61.29% |
Gross Profit | 1,861 | 1,615 | 1,480 | 1,290 | 1,445 | 360 |
% of Revenue | 40.89% | 36.43% | 34.34% | 32.49% | 36.66% | 38.71% |
Operating Income | 372 | 292 | 176 | 94 | 262 | 73 |
% of Revenue | 8.17% | 6.59% | 4.08% | 2.37% | 6.65% | 7.85% |
Interest Expense | 232 | 261 | 318 | 290 | 297 | 82 |
Income Before Tax | 163 | 89 | -115 | -158 | 32 | 10 |
Net Income | 109 | 56 | -99 | -210 | 20 | 5 |
Income in US Dollars
[Income Statement for JW Daihan Pharmaceutical co. (Us Dollars '000'000] | ||||||
2009Y | 2010Y | 2011Y | 2012Y | 2013Y | 1Q/2014 | |
Revenue | 455 | 443 | 431 | 397 | 394 | 93 |
Revenue Growth | -2.59% | -2.77% | -7.87% | -0.73% | ||
COGS | 269 | 282 | 283 | 268 | 250 | 57 |
% of Revenue | 59.13% | 63.57% | 65.66% | 67.51% | 63.34% | 61.29% |
Gross Profit | 186 | 162 | 148 | 129 | 145 | 36 |
% of Revenue | 40.87% | 36.43% | 34.34% | 32.49% | 36.66% | 38.71% |
Operating Income | 37 | 29 | 18 | 9 | 26 | 7 |
% of Revenue | 8.17% | 6.59% | 4.08% | 2.37% | 6.65% | 7.85% |
Interest Expense | 23 | 26 | 32 | 29 | 30 | 8 |
Income Before Tax | 16 | 9 | -12 | -16 | 3 | 1 |
Net Income | 11 | 6 | -10 | -21 | 2 | 1 |
댓글 없음:
댓글 쓰기